Mercy BioAnalytics to Present Data at ASCO Evaluating Clinical Performance of a Blood-Based Lung Cancer Early Detection Assay in Biospecimens from the National Lung Screening Trial

Accepted ASCO abstracts highlight Mercy's blood-based lung cancer screening and lung nodule triage programs using specimens from the NLST biorepository, which was established to support validation of early detection lung cancer biomarkers WALTHAM, Mass., May 26, 2026 /PRNewswire/ -- Mercy...